BrightSpring Health Services Files 8-K

TL;DR

BrightSpring Health Services filed an 8-K on Dec 11, 2024, detailing a new financial obligation.

AI Summary

On December 11, 2024, BrightSpring Health Services, Inc. entered into a material definitive agreement related to the creation of a direct financial obligation. The company also made a Regulation FD disclosure and filed financial statements and exhibits.

Why It Matters

This filing indicates a significant financial event or obligation for BrightSpring Health Services, which could impact its financial standing and investor outlook.

Risk Assessment

Risk Level: medium — The filing pertains to a material definitive agreement and a direct financial obligation, suggesting potential financial risks or opportunities that warrant further investigation.

Key Players & Entities

• BrightSpring Health Services, Inc. (company) — Registrant
• December 11, 2024 (date) — Date of earliest event reported

FAQ

Key Financial Figures

• $0.01 — ch registered Common Stock, par value $0.01 per share BTSG The Nasdaq Stock Mar
• $2,553,170,000 — an aggregate principal amount equal to $2,553,170,000, the proceeds of which will be used to

Filing Documents

• btsg-20241211.htm (8-K) — 58KB
• btsg-ex10_1.htm (EX-10.1) — 3133KB
• btsg-ex99_1.htm (EX-99.1) — 11KB
• 0000950170-24-135375.txt ( ) — 3749KB
• btsg-20241211.xsd (EX-101.SCH) — 44KB
• btsg-20241211_htm.xml (XML) — 6KB

01 Entry into a Material Definitive Agreement

Item 1.01 Entry into a Material Definitive Agreement. On December 11, 2024, Phoenix Intermediate Holdings Inc. (" Holdings ") and Phoenix Guarantor Inc. (the " Borrower "), each a wholly-owned subsidiary of BrightSpring Health Services, Inc. (" BrightSpring "), entered into Amendment No. 9 (the " Amendment ") to the First Lien Credit Agreement, dated as of March 5, 2019 (as amended by the Technical Amendment, dated May 13, 2019, as supplemented by the Joinder Agreement, dated as of September 30, 2019, as amended by Amendment No. 1, dated as of January 30, 2020, as amended by the Joinder Agreement and Amendment No. 2, dated as of June 30, 2020, as amended by the Joinder Agreement and Amendment No. 3, dated as of October 7, 2020, as amended by Amendment No. 4, dated as of April 8, 2021, as amended by the Joinder Agreement and Amendment No. 5, dated as of April 16, 2021, as amended by the Joinder Agreement and Amendment No. 6, dated as of June 30, 2023, as amended by the Joinder Agreement and Amendment No. 7, dated as of February 21, 2024, and as amended by the Joinder Agreement and Amendment No. 8, dated as of September 17, 2024, the " Credit Agreement ", and as amended by the Amendment, the " Amended Credit Agreement "), by and among Holdings, the Borrower, the several lenders from time to time parties thereto and Morgan Stanley Senior Funding Inc., as administrative agent and collateral agent. The Amendment provides for the establishment of a new tranche of term loans (the " Term Loans ") in an aggregate principal amount equal to $2,553,170,000, the proceeds of which will be used to refinance an equivalent amount of term loans outstanding under the Credit Agreement immediately before giving effect to the Amendment. The Term Loans mature on February 21, 2031, and the revolving loans that separately may be incurred from time to time under the Amended Credit Agreement mature on June 30, 2028. Under the Amended Credit Agreement, loans outstanding under the Amended

01 Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure. In connection with the Amendment, BrightSpring issued a press release on December 11, 2024. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and incorporated by reference in this Item 7.01. The information furnished under this Item 7.01, including Exhibit 99.1, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the " Exchange Act "), or otherwise subject to the liabilities under that section and shall not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as otherwise expressly stated by specific reference in any such filing.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description 10.1 Amendment No. 9, dated as of December 11, 2024, by and among Phoenix Intermediate Holdings Inc., Phoenix Guarantor Inc., the several lenders from time to time parties thereto and Morgan Stanley Senior Funding Inc. as administrative agent and collateral agent to the First Lien Credit Agreement, dated as of March 5, 2019, by and among Phoenix Intermediate Holdings Inc., Phoenix Guarantor Inc., the lenders party thereto, and Morgan Stanley Senior Funding, Inc. (with amended First Lien Credit Agreement attached as Exhibit A). 99.1 Press Release of BrightSpring Health Services, Inc., dated December 11, 2024. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. BRIGHTSPRING HEALTH SERVICES, INC. Date: December 11, 2024 By: /s/ Jennifer Phipps Name: Title: Jennifer Phipps Chief Accounting Officer

View Full Filing

View this 8-K filing on SEC EDGAR